These data agree with the study by Igbal et al. that identified 27 miRNA targets of MYC (11 upregulated and 16 downregulated miRNAs), allowing the differentiation of BL (n = 36 patients) from DLBCL (n = 79 patients) [121]. Here, MYC is linked to diffuse large B-cell lymphoma.